MLTX Stock Price Chart
MLTX Financial
MoonLake Immunotherapeutics
$17.55
-4.56%
$-0.83
At close: May 15, 16:00:00 GMT-4
$17.56
0.06%
$0.01
Post-market: May 15, 20:00:00 GMT-4
Back
MoonLake Immunotherapeutics (MLTX) Financial
Key Stats
Prev.Close
$18.39
Open
$18.26
Day's Range
$17.51 - $18.26
52 week range
$5.95 - $62.75
Volume
584.8K
Avg.Volume
1.6M
Dividend yield
--
EPS (TTM)
-3.52
Market Cap
$1.2B
What is MLTX?
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 130 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
